EmVenio Insights

Durham, NC – May 17, 2023 –       EmVenio Research, a company providing rapid and scalable mobile research sites in order to better reach and recruit diverse, underserved and high-risk communities, has partnered with Socially Determined, a social risk analytics and data…

EmVenio Research attended the World Vaccine Congress in Washington DC earlier this month. The conference, which took place from April 3rd to 6th, brought together industry leaders, scientists, and researchers from around the world to discuss the latest advancements in…

EmVenio Research’s dedication to the community is demonstrated by action. Our passion for engaging local communities is what sets us apart. On March 6th, our mobile Community Research Site was on campus! The students from Georgia Tech School of Industrial…

DURHAM, N.C., April 11, 2023 /PRNewswire/ — EmVenio Research today announced the appointment of Dr. Mark McKenzie, M.D. as its chief medical officer. In this role, Dr. McKenzie will lead and strategize new initiatives in the clinical and therapeutic areas. He will also provide medical…

EmVenio doubles minority participation in clinical trials with geographic and cultural accessibility solution protected by the ClearDATA Managed Health Cloud AUSTIN, Texas, March 30, 2023 (GLOBE NEWSWIRE) — ClearDATA®, the first and most comprehensive provider of healthcare-specific managed cloud, compliance and…

EmVenio president Thad Wolfram spoke to CenterWatch about our innovative approach to expand access and diversity in clinical trials through our fleet of mobile community research sites. Thad discussed how EmVenio was formed and its mission behind the work we…

DURHAM, N.C., March 6, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Orlando, Florida, as part of a concerted effort to maximize diversity, equity and inclusion in research studies and deliver clinical trial access to diverse and underserved communities. EmVenio will…

EmVenio Research is committed to helping you achieve your DEI objectives and meet enrollment goals. With our 10 active Community Research Sites located in geographies providing access to underserved and difficult to reach populations, we enable you to enroll the…

The SCOPE 2023 Summit was a major success, with attendees from all over the world gathering to learn more about the latest developments in the clinical trial industry. The event was full of memorable moments, from keynotes, workshops, and demos…

DURHAM, N.C., Feb. 21, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Claremont, California, as part of a concerted effort to maximize diversity, equity and inclusion in research studies and deliver clinical trial access to diverse and underserved communities. EmVenio will…

DURHAM, N.C., Feb. 16, 2023 – In an effort to maximize diversity, equity and inclusion in clinical research, EmVenio Research activated 10 community research sites among diverse populations across the United States. This concerted effort marks the value EmVenio’s services…

Mobile Community Clinical Research Facility to be Deployed in California Atlanta, GA, February 15, 2023 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, and EmVenio Research, a patient-focused decentralized trial…